Insulin-like growth factor binding protein-4 protease produced by smooth muscle cells increases in the coronary artery after angioplasty

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 21, Issue 3, 2001, Pages 335-341

  Bayes Genis, Antoni ^a   Schwartz, Robert S ^a   Lewis, Debra A ^a   Overgaard, Michael T ^b   Christiansen, Michael ^c   Oxvig, Claus ^b   Ashai, Khalid ^a   Holmes Jr, David R ^a   Conover, Cheryl A ^a  

^a MAYO CLINIC   (United States)

^b AARHUS UNIVERSITY   (Denmark)

^c STATENS SERUM INSTITUT   (Denmark)

Author keywords

Binding protein proteases; Insulin like growth factor; Restenosis

Indexed keywords

MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; PREGNANCY ASSOCIATED PLASMA PROTEIN A; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN C;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SYNTHESIS; FEMALE; HUMAN; HUMAN CELL; INTIMA; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESTENOSIS; SMOOTH MUSCLE FIBER; SWINE; TUNICA MEDIA; WESTERN BLOTTING;

EID: 0035097031     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.21.3.335     Document Type: Article

References (40)

1. Prevention of restenosis after transluminal coronary angioplasty: The search for a "magic bullet"
2. The restenosis paradigm revisited: An alternative proposal for cellular mechanisms
3. Insulin, insulin-like growth factor I and platelet-derived growth factor interact additively in the induction of the protooncogene c-myc and cellular proliferation in cultured bovine aortic smooth muscle cells
4. The insulin-like growth factor axis: A review of atherosclerosis and restenosis
5. Localization of insulin-like growth factor I and inhibition of coronary smooth muscle cell growth by somatostatin analogues in human coronary smooth muscle cells: A potential treatment for restenosis?
6. Regulation of insulin-like growth factor-I and its receptor in rat aorta after balloon denudation: Evidence for local bioactivity
7. Expression of IGF-I, IGF-I receptor and TGF-β following balloon angioplasty in atherosclerotic and normal rabbit iliac arteries: An immunocytochemical study
8. Expression of IGF-I. IGF-I receptor and IGF binding proteins-1, -2, -3, -4 and-5 in human atherectomy specimens
9. Evidence for a functional role of endogenously produced somatomedin-like peptides in the regulation of DNA synthesis in cultured human fibroblasts and porcine smooth muscle cells
10. Ligand occupancy of the αVβ3 integrin is necessary for smooth muscle cells to migrate in response to insulin-like growth factor
11. Insulin-like growth factor-I and platelet-derived growth factor-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation
12. Identification and molecular characterization of insulin-like growth factor binding protein (IGFBP-1, -2, -3, -4, -5, and -6)
13. Posttranslational modification of the IGF binding proteins
14. Vascular smooth muscle cells synthesize two forms of insulin-like growth factor binding proteins (IGFBP) which are regulated differently by the insulin like growth factors
15. Overexpression of insulin-like growth factor binding protein-4 (IGFBP-4) in smooth muscle cells of transgenic mice through a smooth muscle α-actin-IGFBP-4 fusion gene induces smooth muscle hypoplasia
16. Evaluation of the developmental and nutritional changes in porcine insulin-like growth factor binding protein-1 and 2 serum level by immunoassay
17. Properties of an insulin-like growth factor-binding protein-4 protease that is secreted by smooth muscle cells
18. The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy associated plasma protein-A
19. Insulin-like growth factor binding protein-5 is cleaved by physiological concentrations of thrombin
20. Insulin-like growth factor binding protein proteolysis in bone cell models
21. Evidence that the insulin-like growth factor binding protein-4 protease in human ovarian follicular fluid is pregnancy associated plasma protein-A
22. Characterization of four human pregnancy-associated plasma proteins
23. Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy: International Prenatal Screening Research Group
24. Isolation and characterization of circulating complex between human pregnancy-associated plasma protein-A and proform of eosinophil major basic protein
25. Double-monoclonal immunofluorometric assays for pregnancy-associated plasma protein A/proeosinophil major basic protein (PAPP-A/proMBP) complex in first-trimester maternal serum screening for Down syndrome
26. Multiple growth factors are released from mechanically injured vascular smooth muscle cells
27. Restenosis after balloon angioplasty: A practical proliferative model in porcine coronary arteries
28. Endothelial implants inhibit intimal hyperplasia after porcine angioplasty
29. Restenosis and the proportional neointimal response to coronary artery injury: Results in a porcine model
30. Messenger ribonucleic acid levels of pregnancy-associated plasma protein-A and proform of eosinophil major basic protein: Expression in reproductive and non-reproductive tissues
31. Insulin-like growth factor-II enhancement of human fibroblast growth via a nonreceptor-mediated mechanism
32. Regulation of insulin-like growth factor binding protein 4 by specific insulin-like growth factor binding protein 4 proteinase in normal human osteoblast-like cells: Implications in bone cell physiology
33. 2 amino acid sequence analysis
34. An insulin-like growth factor binding protein enhances the biologic response to IGF-I
35. Insulin-like growth factor binding protein 1 stimulates cell migration and binds to the α5β1 integrin by means of its Arg-Gly-Asp sequence
36. Insulin-like growth factor binding protein-1 inhibits arterial smooth muscle cell proliferation in vitro but does not reduce the neointimal response to balloon catheter injury
37. Insulin-like growth factor (IGF)-binding proteins inhibit the smooth muscle cell migration responses to IGF-I and IGF-II
38. Cloning and sequence determination of bovine insulin-like growth factor binding protein-2 (IGFBP-2): Comparison of its structural and functional properties with IGFBP-1
39. Isolation of an inhibitory insulin-like growth factor (IGF) binding protein from bone conditioned medium: A potential local regulator of IGF action
40. Differential expression and biological effects of insulin-like growth factor-binding protein-4 and -5 in vascular smooth muscle cells